Beyond tradition and convention: benefits of non-traditional model organisms in cancer research

1.

Siegel, R. L., Miller, K. D., & Jemal, A. (2020). Cancer statistics, 2020. CA: A Cancer Journal for Clinicians, 70(1), 7–30. https://doi.org/10.3322/caac.21590.CrossRef

2.

Oppermann, H., Levinson, A. D., Varmus, H. E., Levintow, L., & Bishop, J. M. (1979). Uninfected vertebrate cells contain a protein that is closely related to the product of the avian sarcoma virus transforming gene (Src). Proceedings of the National Academy of Sciences of the United States of America, 76(4), 1804–1808. https://doi.org/10.1073/pnas.76.4.1804.CrossRefPubMedPubMedCentral

3.

Irby, R. B., & Yeatman, T. J. (2000). Role of Src expression and activation in human cancer. Oncogene, 19(49), 5636–5642. https://doi.org/10.1038/sj.onc.1203912.CrossRefPubMed

4.

Weiss, R. A., & Vogt, P. K. (2011). 100 years of Rous sarcoma virus. The Journal of Experimental Medicine, 208(12), 2351–2355. https://doi.org/10.1084/jem.20112160.CrossRefPubMedPubMedCentral

5.

Ferreira, R., Limeta, A., & Nielsen, J. (2019). Tackling cancer with yeast-based technologies. Trends in Biotechnology, 37(6), 592–603. https://doi.org/10.1016/j.tibtech.2018.11.013.CrossRefPubMed

6.

Kondo, Y., Kanzawa, T., Sawaya, R., & Kondo, S. (2005). The role of autophagy in cancer development and response to therapy. Nature Reviews Cancer, 5(9), 726–734. https://doi.org/10.1038/nrc1692.CrossRefPubMed

7.

Qu, X., Yu, J., Bhagat, G., Furuya, N., Hibshoosh, H., Troxel, A., et al. (2003). Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. Journal of Clinical Investigation, 112(12), 1809–1820. https://doi.org/10.1172/JCI200320039.CrossRefPubMedCentral

8.

Millburn, G. H., Crosby, M. A., Gramates, L. S., Tweedie, S., & the FlyBase Consortium. (2016). FlyBase portals to human disease research using Drosophila models. Disease Models & Mechanisms, 9(3), 245–252. https://doi.org/10.1242/dmm.023317.CrossRef

9.

Sonoshita, M., & Cagan, R. L. (2017). Modeling human cancers in drosophila. Current Topics in Developmental Biology, 121, 287–309. https://doi.org/10.1016/bs.ctdb.2016.07.008.CrossRefPubMed

10.

Mirzoyan, Z., Sollazzo, M., Allocca, M., Valenza, A. M., Grifoni, D., & Bellosta, P. (2019). Drosophila melanogaster: A model organism to study cancer. Frontiers in Genetics, 10, 51. https://doi.org/10.3389/fgene.2019.00051.CrossRefPubMedPubMedCentral

11.

Kirienko, N. V., Mani, K., & Fay, D. S. (2010). Cancer models in Caenorhabditis elegans. Developmental Dynamics, 239(5), 1413–1448. https://doi.org/10.1002/dvdy.22247.CrossRefPubMedPubMedCentral

12.

Kyriakakis, E., Markaki, M., & Tavernarakis, N. (2015). Caenorhabditis elegans as a model for cancer research. Molecular & Cellular Oncology, 2(2), e975027. https://doi.org/10.4161/23723556.2014.975027.CrossRef

13.

Chávez, M. N., Aedo, G., Fierro, F. A., Allende, M. L., & Egaña, J. T. (2016). Zebrafish as an emerging model organism to study angiogenesis in development and regeneration. Frontiers in Physiology, 7. https://doi.org/10.3389/fphys.2016.00056.

14.

Zhang, B., Shimada, Y., Kuroyanagi, J., Nishimura, Y., Umemoto, N., Nomoto, T., et al. (2014). Zebrafish xenotransplantation model for cancer stem-like cell study and high-throughput screening of inhibitors. Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, 35(12), 11861–11869. https://doi.org/10.1007/s13277-014-2417-8.CrossRef

15.

Santoro, M. M. (2014). Antiangiogenic cancer drug using the zebrafish model. Arteriosclerosis, Thrombosis, and Vascular Biology, 34(9), 1846–1853. https://doi.org/10.1161/ATVBAHA.114.303221.CrossRefPubMed

16.

Astin, J. W., & Crosier, P. S. (2016). Lymphatics, cancer and zebrafish. In D. M. Langenau (Ed.), Cancer and zebrafish (Vol. 916, pp. 199–218). Cham: Springer International Publishing. https://doi.org/10.1007/978-3-319-30654-4_9.CrossRef

17.

Chen, L., Groenewoud, A., Tulotta, C., Zoni, E., Kruithof-de Julio, M., van der Horst, G., et al. (2017). A zebrafish xenograft model for studying human cancer stem cells in distant metastasis and therapy response. Methods in Cell Biology, 138, 471–496. https://doi.org/10.1016/bs.mcb.2016.10.009.CrossRefPubMed

18.

Deming, P., & Kornbluth, S. (2006). Study of apoptosis in vitro using the xenopus egg extract reconstitution system. In X. J. Liu (Ed.), Xenopus Protocols (Vol. 322, pp. 379–393). Totowa, NJ: Humana Press. https://doi.org/10.1007/978-1-59745-000-3_27.CrossRef

19.

Hardwick, L. J. A., & Philpott, A. (2018). Xenopus models of cancer: Expanding the oncologist’s toolbox. Frontiers in Physiology, 9. https://doi.org/10.3389/fphys.2018.01660.

20.

Hardwick, L. J. A., & Philpott, A. (2015). An oncologist′s friend: How Xenopus contributes to cancer research. Developmental Biology, 408(2), 180–187. https://doi.org/10.1016/j.ydbio.2015.02.003.CrossRefPubMedPubMedCentral

21.

Liu, Y., Yin, T., Feng, Y., Cona, M. M., Huang, G., Liu, J., et al. (2015). Mammalian models of chemically induced primary malignancies exploitable for imaging-based preclinical theragnostic research. Quantitative Imaging in Medicine and Surgery, 5(5), 708–729. https://doi.org/10.3978/j.issn.2223-4292.2015.06.01.CrossRefPubMedPubMedCentral

22.

Buqué, A., & Galluzzi, L. (2018). Modeling tumor immunology and immunotherapy in mice. Trends in Cancer, 4(9), 599–601. https://doi.org/10.1016/j.trecan.2018.07.003.CrossRefPubMed

23.

Cheon, D.-J., & Orsulic, S. (2011). Mouse models of cancer. Annual Review of Pathology, 6, 95–119. https://doi.org/10.1146/annurev.pathol.3.121806.154244.CrossRefPubMed

24.

Xue, W., Chen, S., Yin, H., Tammela, T., Papagiannakopoulos, T., Joshi, N. S., et al. (2014). CRISPR-mediated direct mutation of cancer genes in the mouse liver. Nature, 514(7522), 380–384. https://doi.org/10.1038/nature13589.CrossRefPubMedPubMedCentral

25.

Meek, S., Mashimo, T., & Burdon, T. (2017). From engineering to editing the rat genome. Mammalian Genome, 28(7), 302–314. https://doi.org/10.1007/s00335-017-9705-8.CrossRefPubMedPubMedCentral

26.

Lunardi, A., Nardella, C., Clohessy, J. G., & Pandolfi, P. P. (2014). Of model pets and cancer models: An introduction to mouse models of cancer. Cold Spring Harbor Protocols, 2014(1), 17–31. https://doi.org/10.1101/pdb.top069757.CrossRefPubMed

27.

Gómez-Cuadrado, L., Tracey, N., Ma, R., Qian, B., & Brunton, V. G. (2017). Mouse models of metastasis: Progress and prospects. Disease Models & Mechanisms, 10(9), 1061–1074. https://doi.org/10.1242/dmm.030403.CrossRef

28.

Brown, H. K., Schiavone, K., Tazzyman, S., Heymann, D., & Chico, T. J. (2017). Zebrafish xenograft models of cancer and metastasis for drug discovery. Expert Opinion on Drug Discovery, 12(4), 379–389. https://doi.org/10.1080/17460441.2017.1297416.CrossRefPubMed

29.

Harman, R. M., Curtis, T. M., Argyle, D. J., Coonrod, S. A., & Van de Walle, G. R. (2016). A comparative study on the in vitro effects of the DNA methyltransferase inhibitor 5-Azacytidine (5-AzaC) in breast/mammary cancer of different mammalian species. Journal of Mammary Gland Biology and Neoplasia, 1–6.

30.

Zhang, H., Pei, S., Zhou, B., Wang, H., Du, H., Zhang, D., & Lin, D. (2018). Establishment and characterization of a new triple-negative canine mammary cancer cell line. Tissue and Cell, 54, 10–19. https://doi.org/10.1016/j.tice.2018.07.003.CrossRefPubMed

31.

Hong, S. H., Kadosawa, T., Mochizuki, M., Matsunaga, S., Nishimura, R., & Sasaki, N. (1998). Establishment and characterization of two cell lines derived from canine spontaneous osteosarcoma. The Journal of Veterinary Medical Science, 60(6), 757–760. https://doi.org/10.1292/jvms.60.757.CrossRefPubMed

32.

Legare, M. E., Bush, J., Ashley, A. K., Kato, T., & Hanneman, W. H. (2011). Cellular and phenotypic characterization of canine osteosarcoma cell lines. Journal of Cancer, 2, 262–270. https://doi.org/10.7150/jca.2.262.CrossRefPubMedPubMedCentral

33.

Wilson-Robles, H., Franks, K., Pool, R., & Miller, T. (2019). Characterization of five newly derived canine osteosarcoma cell lines. BMC Veterinary Research, 15(1), 357. https://doi.org/10.1186/s12917-019-2099-y.CrossRefPubMedPubMedCentral

34.

Nytko, K. J., Thumser-Henner, P., Weyland, M. S., Scheidegger, S., & Rohrer Bley, C. (2019). Cell line-specific efficacy of thermoradiotherapy in human and canine cancer cells in vitro. PLoS One, 14(5), e0216744. https://doi.org/10.1371/journal.pone.0216744.CrossRefPubMedPubMedCentral

35.

Nakaichi, M., Taura, Y., Kanki, M., Mamba, K., Momoi, Y., Tsujimoto, H., & Nakama, S. (1996). Establishment and characterization of a new canine B-cell leukemia cell line. The Journal of Veterinary Medical Science, 58(5), 469–471. https://doi.org/10.1292/jvms.58.469.CrossRefPubMed

36.

Momoi, Y., Okai, Y., Watari, T., Goitsuka, R., Tsujimoto, H., & Hasegawa, A. (1997). Establishment and characterization of a canine T-lymphoblastoid cell line derived from malignant lymphoma. Veterinary Immunology and Immunopathology, 59(1), 11–20. https://doi.org/10.1016/S0165-2427(97)00053-6.CrossRefPubMed

37.

Kisseberth, W. C., Nadella, M. V. P., Breen, M., Thomas, R., Duke, S. E., Murahari, S., et al. (2007). A novel canine lymphoma cell line: A translational and comparative model for lymphoma research. Leukemia Research, 31(12), 1709–1720. https://doi.org/10.1016/j.leukres.2007.04.003.CrossRefPubMed

38.

Rütgen, B. C., Hammer, S. E., Gerner, W., Christian, M., de Arespacochaga, A. G., Willmann, M., et al. (2010). Establishment and characterization of a novel canine B-cell line derived from a spontaneously occurring diffuse large cell lymphoma. Leukemia Research, 34(7), 932–938. https://doi.org/10.1016/j.leukres.2010.01.021.CrossRefPubMed

39.

Zwingenberger, A. L., Vernau, W., Shi, C., Yan, W., Chen, X., Gordon, I. K., & Kent, M. S. (2012). Development and characterization of 5 canine B-cell lymphoma cell lines. Leukemia Research, 36(5), 601–606. https://doi.org/10.1016/j.leukres.2011.11.004.CrossRefPubMed

40.

Umeki, S., Ema, Y., Suzuki, R., Kubo, M., Hayashi, T., Okamura, Y., et al. (2013). Establishment of five canine lymphoma cell lines and tumor formation in a xenotransplantation model. The Journal of Veterinary Medical Science, 75(4), 467–474. https://doi.org/10.1292/jvms.12-0448.CrossRefPubMed

41.

Bonnefont-Rebeix, C., Fournel-Fleury, C., Ponce, F., Belluco, S., Watrelot, D., Bouteille, S. E., et al. (2016). Characterization of a novel canine T-cell line established from a spontaneously occurring aggressive T-cell lymphoma with large granular cell morphology. Immunobiology, 221(1), 12–22. https://doi.org/10.1016/j.imbio.2015.08.007.CrossRefPubMed

42.

Andrews, A., Wang, Z., Wilkinson, R., Fishman, J., Sachs, D., Navarro Alvarez, N., & Huang, C. (January 12). Development of transplantable B-cell lymphomas in the MHC-defined miniature swine model. Cancer Cell International, 19. https://doi.org/10.1186/s12935-019-0954-3.

43.

Rahe, M. C., Dvorak, C. M. T., Wiseman, B., Martin, D., & Murtaugh, M. P. (2020). Establishment and characterization of a porcine B cell lymphoma cell line. Experimental Cell Research, 390(2), 111986. https://doi.org/10.1016/j.yexcr.2020.111986.CrossRefPubMed

44.

Donninger, H., Hobbing, K., Schmidt, M. L., Walters, E., Rund, L., Schook, L., & Clark, G. J. (2015). A porcine model system of BRCA1 driven breast cancer. Frontiers in Genetics, 6, 269. https://doi.org/10.3389/fgene.2015.00269.CrossRefPubMedPubMedCentral

45.

Rowson-Hodel, A. R., Manjarin, R., Trott, J. F., Cardiff, R. D., Borowsky, A. D., & Hovey, R. C. (2015). Neoplastic transformation of porcine mammary epithelial cells in vitro and tumor formation in vivo. BMC Cancer, 15(1), 562. https://doi.org/10.1186/s12885-015-1572-7.CrossRefPubMedPubMedCentral

46.

Rauner, G., Ledet, M. M., & Van de Walle, G. R. (2018). Conserved and variable: Understanding mammary stem cells across species. Cytometry Part A, 93(1), 125–136. https://doi.org/10.1002/cyto.a.23190.CrossRef

47.

Lai, C.-L., van den Ham, R., van Leenders, G., van der Lugt, J., Mol, J. A., & Teske, E. (2008). Histopathological and immunohistochemical characterization of canine prostate cancer. The Prostate, 68(5), 477–488. https://doi.org/10.1002/pros.20720.CrossRefPubMed

48.

Maya-Pulgarin, D., Gonzalez-Dominguez, M. S., Aranzazu-Taborda, D., Mendoza, N., & Maldonado-Estrada, J. G. (2017). Histopathologic findings in uteri and ovaries collected from clinically healthy dogs at elective ovariohysterectomy: A cross-sectional study. Journal of Veterinary Science, 18(3), 407–414. https://doi.org/10.4142/jvs.2017.18.3.407.CrossRefPubMedPubMedCentral

49.

Luu, A., Macdonald, R., Oblak, M., Brisson, B., & Viloria-Petit, A. (2018). Optimization of an explant culture model to characterize cancer-associated exosomes in canine osteosarcoma.

50.

Brozyna, A., & Chwirot, B. W. (2006). Porcine skin as a model system for studies of ultraviolet a effects in human skin. Journal of Toxicology and Environmental Health, Part A, 69(12), 1155–1165. https://doi.org/10.1080/15287390500360323.CrossRef

51.

Brożyna, A., Wasilewska, K., Węsierska, K., & Chwirot, B. W. (2009). Porcine skin as a model system for studies of adverse effects of narrow-band UVB pulses on human skin. Journal of Toxicology and Environmental Health, Part A, 72(13), 789–795. https://doi.org/10.1080/15287390902800363.CrossRef

52.

Cousens, C., Alleaume, C., Bijsmans, E., Martineau, H. M., Finlayson, J., Dagleish, M. P., & Griffiths, D. J. (2015). Jaagsiekte sheep retrovirus infection of lung slice cultures. Retrovirology, 12, 31. https://doi.org/10.1186/s12977-015-0157-5.CrossRefPubMedPubMedCentral

53.

Cocola, C., Molgora, S., Piscitelli, E., Veronesi, M. C., Greco, M., Bragato, C., et al. (2017). FGF2 and EGF are required for self-renewal and organoid formation of canine normal and tumor breast stem cells. Journal of Cellular Biochemistry, 118(3), 570–584. https://doi.org/10.1002/jcb.25737.CrossRefPubMed

54.

Usui, T., Sakurai, M., Nishikawa, S., Umata, K., Nemoto, Y., Haraguchi, T., et al. (2017). Establishment of a dog primary prostate cancer organoid using the urine cancer stem cells. Cancer Science, 108(12), 2383–2392. https://doi.org/10.1111/cas.13418.CrossRefPubMedPubMedCentral

55.

Elbadawy, M., Usui, T., Mori, T., Tsunedomi, R., Hazama, S., Nabeta, R., et al. (2019). Establishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture. Cancer Science, 110(9), 2806–2821. https://doi.org/10.1111/cas.14118.CrossRefPubMedPubMedCentral

56.

Chandra, L., Borcherding, D. C., Kingsbury, D., Atherly, T., Ambrosini, Y. M., Bourgois-Mochel, A., et al. (2019). Derivation of adult canine intestinal organoids for translational research in gastroenterology. BMC Biology, 17(1), 33. https://doi.org/10.1186/s12915-019-0652-6.CrossRefPubMedPubMedCentral

57.

Hassan, B. B., Elshafae, S. M., Supsavhad, W., Simmons, J. K., Dirksen, W. P., Sokkar, S. M., & Rosol, T. J. (2017). Feline mammary cancer: Novel nude mouse model and molecular characterization of invasion and metastasis genes. Veterinary Pathology, 54(1), 32–43. https://doi.org/10.1177/0300985816650243.CrossRefPubMed

58.

Ledet, M. M., Anderson, R., Harman, R., Muth, A., Thompson, P. R., Coonrod, S. A., & Van de Walle, G. R. (2018). BB-Cl-Amidine as a novel therapeutic for canine and feline mammary cancer via activation of the endoplasmic reticulum stress pathway. BMC Cancer, 18(1), 412. https://doi.org/10.1186/s12885-018-4323-8.CrossRefPubMedPubMedCentral

59.

Weiskopf, K., Anderson, K. L., Ito, D., Schnorr, P. J., Tomiyasu, H., Ring, A. M., et al. (2016). Eradication of canine diffuse large B-cell lymphoma in a murine xenograft model with CD47 blockade and anti-CD20. Cancer Immunology Research, 4(12), 1072. https://doi.org/10.1158/2326-6066.CIR-16-0105.CrossRefPubMedPubMedCentral

60.

Im, K. S., Kim, J. H., Graef, A. J., Cornax, I., Seelig, D. M., O’Sullivan, M. G., et al. (2017). Establishment of a patient-derived xenograft of canine enteropathy-associated T-cell lymphoma, large cell type. Journal of Comparative Pathology, 156(1), 37–41. https://doi.org/10.1016/j.jcpa.2016.11.271.CrossRefPubMed

61.

Akhtar, N., Padilla, M. L., Dickerson, E. B., Steinberg, H., Breent, M., Auerbach, R., & Helfand, S. C. (2004). Interleukin-12 inhibits tumor growth in a novel angiogenesis canine hemangiosarcoma xenograft model. Neoplasia, 6(2), 106–116. https://doi.org/10.1593/neo.03334.CrossRefPubMedPubMedCentral

62.

Boettcher, A. N., Kiupel, M., Adur, M. K., Cocco, E., Santin, A. D., Bellone, S., et al. (2019). Human ovarian cancer tumor formation in severe combined Immunodeficient (SCID) pigs. Frontiers in Oncology, 9, 9. https://doi.org/10.3389/fonc.2019.00009.CrossRefPubMedPubMedCentral

63.

Luo, Y., Li, J., Liu, Y., Lin, L., Du, Y., Li, S., et al. (2011). High efficiency of BRCA1 knockout using rAAV-mediated gene targeting: Developing a pig model for breast cancer. Transgenic Research, 20(5), 975–988. https://doi.org/10.1007/s11248-010-9472-8.CrossRefPubMed

64.

Flisikowska, T., Merkl, C., Landmann, M., Eser, S., Rezaei, N., Cui, X., et al. (2012). A porcine model of familial adenomatous polyposis. Gastroenterology, 143(5), 1173–1175.e7. https://doi.org/10.1053/j.gastro.2012.07.110.CrossRefPubMed

65.

Flisikowska, T., Stachowiak, M., Xu, H., Wagner, A., Hernandez-Caceres, A., Wurmser, C., et al. (2017). Porcine familial adenomatous polyposis model enables systematic analysis of early events in adenoma progression. Scientific Reports, 7(1), 6613. https://doi.org/10.1038/s41598-017-06741-8.CrossRefPubMedPubMedCentral

66.

Callesen, M. M., Árnadóttir, S. S., Lyskjaer, I., Ørntoft, M. W., Høyer, S., Dagnaes-Hansen, F., et al. (2017). A genetically inducible porcine model of intestinal cancer. Molecular Oncology, 11(11), 1616–1629. https://doi.org/10.1002/1878-0261.12136.CrossRefPubMedPubMedCentral

67.

Leuchs, S., Saalfrank, A., Merkl, C., Flisikowska, T., Edlinger, M., Durkovic, M., et al. (2012). Inactivation and inducible oncogenic mutation of p53 in gene targeted pigs. PLoS One, 7(10), e43323–e43323. https://doi.org/10.1371/journal.pone.0043323.CrossRefPubMedPubMedCentral

68.

Sieren, J. C., Meyerholz, D. K., Wang, X.-J., Davis, B. T., Newell Jr., J. D., Hammond, E., et al. (February 9). Development and translational imaging of a TP53 porcine tumorigenesis model. The Journal of Clinical Investigation, 124(9), 4052–4066. https://doi.org/10.1172/JCI75447.

69.

Schook, L. B., Collares, T. V., Hu, W., Liang, Y., Rodrigues, F. M., Rund, L. A., et al. (2015). A genetic porcine model of cancer. PLoS One, 10(7), e0128864. https://doi.org/10.1371/journal.pone.0128864.CrossRefPubMedPubMedCentral

70.

Schachtschneider, K. M., Schwind, R. M., Darfour-Oduro, K. A., De, A. K., Rund, L. A., Singh, K., et al. (2017). A validated, transitional and translational porcine model of hepatocellular carcinoma. Oncotarget, 8(38), 63620–63634. https://doi.org/10.18632/oncotarget.18872.CrossRefPubMedPubMedCentral

71.

Principe, D. R., Overgaard, N. H., Park, A. J., Diaz, A. M., Torres, C., McKinney, R., et al. (2018). KRASG12D and tp53r167h cooperate to induce pancreatic ductal adenocarcinoma in sus scrofa pigs. Scientific Reports, 8(1), 12548. https://doi.org/10.1038/s41598-018-30916-6.CrossRefPubMedPubMedCentral

72.

Sharma, A., Benbrook, D. M., & Woo, S. (2018). Pharmacokinetics and interspecies scaling of a novel, orally-bioavailable anti-cancer drug, SHetA2. PLoS One, 13(4), e0194046. https://doi.org/10.1371/journal.pone.0194046.CrossRefPubMedPubMedCentral

73.

Zhang, C., Zhang, X., Wang, G., Peng, Y., Zhang, X., Wu, H., et al. (2018). Preclinical pharmacokinetics of C118P, a novel prodrug of microtubules inhibitor and its metabolite C118 in mice, rats, and dogs. Molecules (Basel, Switzerland), 23(11), 2883. https://doi.org/10.3390/molecules23112883.CrossRef

74.

Weir, S. J., Wood, R., Schorno, K., Brinker, A. E., Ramamoorthy, P., Heppert, K., et al. (2019). Preclinical pharmacokinetics of Fosciclopirox, a novel treatment of Urothelial cancers, in rats and dogs. The Journal of Pharmacology and Experimental Therapeutics, 370(2), 148–159. https://doi.org/10.1124/jpet.119.257972.CrossRefPubMedPubMedCentral

75.

Panjwani, M. K., Smith, J. B., Schutsky, K., Gnanandarajah, J., O’Connor, C. M., Powell Jr., D. J., & Mason, N. J. (2016). Feasibility and safety of RNA-transfected CD20-specific chimeric antigen receptor T cells in dogs with spontaneous B cell lymphoma. Molecular Therapy, 24(9), 1602–1614. https://doi.org/10.1038/mt.2016.146.CrossRefPubMedPubMedCentral

76.

Mochel, J. P., Ekker, S. C., Johannes, C. M., Jergens, A. E., Allenspach, K., Bourgois-Mochel, A., et al. (2019). Car t cell immunotherapy in human and veterinary oncology: Changing the odds against hematological malignancies. The AAPS Journal, 21(3), 50. https://doi.org/10.1208/s12248-019-0322-1.CrossRefPubMed

77.

Chen, K., Huang, Y. H., & Chen, J. L. (2013). Understanding and targeting cancer stem cells: Therapeutic implications and challenges. Acta Pharmacologica Sinica, 34(6), 732–740. https://doi.org/10.1038/aps.2013.27.CrossRefPubMedPubMedCentral

78.

Rybicka, A., & Król, M. (2016). Identification and characterization of cancer stem cells in canine mammary tumors. Acta Veterinaria Scandinavica, 58(1), 86. https://doi.org/10.1186/s13028-016-0268-6.CrossRefPubMedPubMedCentral

79.

Spaas, J. H., Chiers, K., Bussche, L., Burvenich, C., & Van de Walle, G. R. (2012). Stem/progenitor cells in non-lactating versus lactating equine mammary gland. Stem Cells and Development, 21(16), 3055–3067. https://doi.org/10.1089/scd.2012.0042.CrossRefPubMed

80.

Borena, B. M., Bussche, L., Burvenich, C., Duchateau, L., & Van de Walle, G. R. (2013). Mammary stem cell research in veterinary science: An update. Stem Cells and Development, 22(12), 1743–1751. https://doi.org/10.1089/scd.2012.0677.CrossRefPubMedPubMedCentral

81.

Bussche, L., Rauner, G., Antonyak, M., Syracuse, B., McDowell, M., Brown, A. M., et al. (2016). Microvesicle-mediated Wnt/β-catenin signaling promotes interspecies mammary stem/progenitor cell growth. The Journal of Biological Chemistry, 291(47), 24390–24405. https://doi.org/10.1074/jbc.M116.726117.CrossRefPubMedPubMedCentral

82.

Stackhouse, C. T., Gillespie, G. Y., & Willey, C. D. (2019). Cancer Explant Models. Current Topics in Microbiology and Immunology. https://doi.org/10.1007/82_2019_157.

83.

Fatehullah, A., Tan, S. H., & Barker, N. (2016). Organoids as an in vitro model of human development and disease. Nature Cell Biology, 18(3), 246–254. https://doi.org/10.1038/ncb3312.CrossRefPubMed

84.

Russell, W. M. S., & Burch, R. L. (1959). The principles of humane experimental technique. London: Methuen & Co. Ltd..

85.

Flisikowska, T., Kind, A., & Schnieke, A. (2016). Pigs as models of human cancers. Theriogenology, 86(1), 433–437. https://doi.org/10.1016/j.theriogenology.2016.04.058.CrossRefPubMed

86.

Perleberg, C., Kind, A., & Schnieke, A. (2018). Genetically engineered pigs as models for human disease. Disease Models & Mechanisms, 11(1). https://doi.org/10.1242/dmm.030783.

87.

Kalla, D., Kind, A., & Schnieke, A. (2020). Genetically engineered pigs to study Cancer. International Journal of Molecular Sciences, 21(2). https://doi.org/10.3390/ijms21020488.

88.

Wong, C. H., Siah, K. W., & Lo, A. W. (2019). Estimation of clinical trial success rates and related parameters. Biostatistics (Oxford, England), 20(2), 273–286. https://doi.org/10.1093/biostatistics/kxx069.CrossRef

89.

Attarwala, H. (2010). TGN1412: From discovery to disaster. Journal of Young Pharmacists, 2(3), 332–336. https://doi.org/10.4103/0975-1483.66810.CrossRefPubMed

90.

Mak, I. W., Evaniew, N., & Ghert, M. (2014). Lost in translation: Animal models and clinical trials in cancer treatment. American Journal of Translational Research, 6(2), 114–118.PubMedPubMedCentral

91.

Gardner, H. L., Fenger, J. M., & London, C. A. (2016). Dogs as a model for Cancer. Annual Review of Animal Biosciences, 4, 199–222. https://doi.org/10.1146/annurev-animal-022114-110911.CrossRefPubMed

92.

Tarone, L., Barutello, G., Iussich, S., Giacobino, D., Quaglino, E., Buracco, P., et al. (2019). Naturally occurring cancers in pet dogs as pre-clinical models for cancer immunotherapy. Cancer Immunology, Immunotherapy, 68(11), 1839–1853. https://doi.org/10.1007/s00262-019-02360-6.CrossRefPubMed

93.

Duran-Struuck, R., Huang, C. A., & Matar, A. J. (2019). Cellular therapies for the treatment of hematological malignancies; swine are an ideal preclinical model. Frontiers in Oncology, 9, 418. https://doi.org/10.3389/fonc.2019.00418.CrossRefPubMedPubMedCentral

94.

Kabirov, K. K., Kapetanovic, I. M., Benbrook, D. M., Dinger, N., Mankovskaya, I., Zakharov, A., et al. (2013). Oral toxicity and pharmacokinetic studies of SHetA2, a new chemopreventive agent, in rats and dogs. Drug and Chemical Toxicology, 36(3), 284–295. https://doi.org/10.3109/01480545.2012.710632.CrossRefPubMed

95.

Feins, S., Kong, W., Williams, E. F., Milone, M. C., & Fraietta, J. A. (2019). An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer. American Journal of Hematology, 94(S1), S3–s9. https://doi.org/10.1002/ajh.25418.CrossRefPubMed

96.

Ito, D., Frantz, A. M., & Modiano, J. F. (2014). Canine lymphoma as a comparative model for human non-Hodgkin lymphoma: Recent progress and applications. Veterinary Immunology and Immunopathology, 159(3), 192–201. https://doi.org/10.1016/j.vetimm.2014.02.016.CrossRefPubMedPubMedCentral

97.

Ostrander, E. A., Dreger, D. L., & Evans, J. M. (2019). Canine Cancer genomics: Lessons for canine and human health. Annual Review of Animal Biosciences, 7(1), 449–472. https://doi.org/10.1146/annurev-animal-030117-014523.CrossRefPubMed

98.

Abdelmegeed, S., & Mohammed, S. (2018). Canine mammary tumors as a model for human disease (review). Oncology Letters. https://doi.org/10.3892/ol.2018.8411.

99.

Rowell, J. L., McCarthy, D. O., & Alvarez, C. E. (2011). Dog models of naturally occurring cancer. Trends in Molecular Medicine, 17(7), 380–388. https://doi.org/10.1016/j.molmed.2011.02.004.CrossRefPubMedPubMedCentral

100.

Paoloni, M., & Khanna, C. (2008). Translation of new cancer treatments from pet dogs to humans. Nature Reviews Cancer, 8(2), 147–156. https://doi.org/10.1038/nrc2273.CrossRefPubMed

101.

Vilhena, H., Figueira, A. C., Schmitt, F., Canadas, A., Chaves, R., Gama, A., & Dias-Pereira, P. (2020). Canine and feline spontaneous mammary Tumours as models of human breast Cancer (pp. 173–207). https://doi.org/10.1007/978-3-030-30734-9_9.

102.

Galac, S., & Korpershoek, E. (2017). Pheochromocytomas and paragangliomas in humans and dogs: Pheochromocytomas and paragangliomas. Veterinary and Comparative Oncology, 15(4), 1158–1170. https://doi.org/10.1111/vco.12291.CrossRefPubMed

103.

Atherton, M. J., Morris, J. S., McDermott, M. R., & Lichty, B. D. (2016). Cancer immunology and canine malignant melanoma: A comparative review. Veterinary Immunology and Immunopathology, 169, 15–26. https://doi.org/10.1016/j.vetimm.2015.11.003.CrossRefPubMed

104.

Hicks, J., Platt, S., Kent, M., & Haley, A. (2017). Canine brain tumours: A model for the human disease? Canine brain tumours. Veterinary and Comparative Oncology, 15(1), 252–272. https://doi.org/10.1111/vco.12152.CrossRefPubMed

105.

Casal, M., & Haskins, M. (2006). Large animal models and gene therapy. European Journal of Human Genetics, 14(3), 266–272.CrossRef

106.

Dhawan, D., Paoloni, M., Shukradas, S., Choudhury, D. R., Craig, B. A., Ramos-Vara, J. A., et al. (2015). Comparative gene expression analyses identify luminal and basal subtypes of canine invasive Urothelial carcinoma that mimic patterns in human invasive bladder Cancer. PLoS One, 10(9), e0136688. https://doi.org/10.1371/journal.pone.0136688.CrossRefPubMedPubMedCentral

107.

Ranieri, G., Gadaleta, C. D., Patruno, R., Zizzo, N., Daidone, M. G., Hansson, M. G., et al. (2013). A model of study for human cancer: Spontaneous occurring tumors in dogs. Biological features and translation for new anticancer therapies. Critical Reviews in Oncology/Hematology, 88(1), 187–197. https://doi.org/10.1016/j.critrevonc.2013.03.005.CrossRefPubMed

108.

Rusk, A., McKeegan, E., Haviv, F., Majest, S., Henkin, J., & Khanna, C. (2006). Preclinical evaluation of antiangiogenic thrombospondin-1 peptide mimetics, ABT-526 and ABT-510, in companion dogs with naturally occurring cancers. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 12(24), 7444–7455. https://doi.org/10.1158/1078-0432.CCR-06-0109.CrossRef

109.

Pryer, N. K., Lee, L. B., Zadovaskaya, R., Yu, X., Sukbuntherng, J., Cherrington, J. M., & London, C. A. (2003). Proof of target for SU11654: Inhibition of KIT phosphorylation in canine mast cell tumors. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 9(15), 5729–5734.

110.

London, C. A., Hannah, A. L., Zadovoskaya, R., Chien, M. B., Kollias-Baker, C., Rosenberg, M., et al. (2003). Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 9(7), 2755–2768.

111.

Valli, V. E., Myint, M. S., Barthel, A., Bienzle, D., Caswell, J., Colbatzky, F., et al. (2011). Classification of canine malignant lymphomas according to the World Health Organization criteria. Veterinary Pathology, 48(1), 198–211. https://doi.org/10.1177/0300985810379428.CrossRefPubMed

112.

Patrick, D. J., Fitzgerald, S. D., Sesterhenn, I. A., Davis, C. J., & Kiupel, M. (2006). Classification of canine urinary bladder Urothelial Tumours based on the World Health Organization/International Society of Urological Pathology Consensus Classification. Journal of Comparative Pathology, 135(4), 190–199. https://doi.org/10.1016/j.jcpa.2006.07.002.CrossRefPubMed

113.

Horta, R. S., Lavalle, G. E., Monteiro, L. N., Souza, M. C. C., Cassali, G. D., & Araújo, R. B. (2018). Assessment of canine mast cell tumor mortality risk based on clinical, histologic, Immunohistochemical, and molecular features. Veterinary Pathology, 55(2), 212–223. https://doi.org/10.1177/0300985817747325.CrossRefPubMed

114.

Simpson, S., Dunning, M. D., de Brot, S., Grau-Roma, L., Mongan, N. P., & Rutland, C. S. (2017). Comparative review of human and canine osteosarcoma: Morphology, epidemiology, prognosis, treatment and genetics. Acta Veterinaria Scandinavica, 59(1), 71. https://doi.org/10.1186/s13028-017-0341-9.CrossRefPubMedPubMedCentral

115.

Davis, B. W., & Ostrander, E. A. (2014). Domestic dogs and cancer research: A breed-based genomics approach. ILAR Journal, 55(1), 59–68. https://doi.org/10.1093/ilar/ilu017.CrossRefPubMedPubMedCentral

116.

Jeffree, G. M., Price, C. H., & Sissons, H. A. (1975). The metastatic patterns of osteosarcoma. British Journal of Cancer, 32(1), 87–107. https://doi.org/10.1038/bjc.1975.136.CrossRefPubMedPubMedCentral

117.

Tabone, M. D., Kalifa, C., Rodary, C., Raquin, M., Valteau-Couanet, D., & Lemerle, J. (1994). Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 12(12), 2614–2620. https://doi.org/10.1200/JCO.1994.12.12.2614.CrossRef

118.

Saha, D., Saha, K., Banerjee, A., & Jash, D. (2013). Osteosarcoma relapse as pleural metastasis. South Asian Journal of Cancer, 2(2), 56. https://doi.org/10.4103/2278-330X.110483.CrossRefPubMedPubMedCentral

119.

Richards, K. L., & Suter, S. E. (2015). Man’s best friend: What can pet dogs teach us about non-Hodgkin’s lymphoma? Immunological Reviews, 263(1), 173–191. https://doi.org/10.1111/imr.12238.CrossRefPubMedPubMedCentral

120.

Krol, A. D. G., le Cessie, S., Snijder, S., Kluin-Nelemans, J. C., Kluin, P. M., & Noordijk, E. M. (2003). Primary extranodal non-Hodgkin’s lymphoma (NHL): The impact of alternative definitions tested in the comprehensive Cancer Centre west population-based NHL registry. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 14(1), 131–139. https://doi.org/10.1093/annonc/mdg004.CrossRef

121.

Seo, K.-W., Choi, U.-S., Lee, J.-B., Kim, M.-I., Oh, Y.-I., Chung, J.-Y., et al. (2011). Central nervous system relapses in 3 dogs with B-cell lymphoma. The Canadian Veterinary Journal = La Revue Veterinaire Canadienne, 52(7), 778–783.PubMedPubMedCentral

122.

Gray, M., Meehan, J., Martínez-Pérez, C., Kay, C., Turnbull, A. K., Morrison, L. R., et al. (2020). Naturally-occurring canine mammary tumors as a translational model for human breast Cancer. Frontiers in Oncology, 10, 617. https://doi.org/10.3389/fonc.2020.00617.CrossRefPubMedPubMedCentral

123.

Queiroga, F. L., Raposo, T., Carvalho, M. I., Prada, J., & Pires, I. (2011). Canine mammary tumours as a model to study human breast cancer: Most recent findings. In Vivo (Athens, Greece), 25(3), 455–465.

124.

Sorenmo, K. (2003). Canine mammary gland tumors. Veterinary Clinics of North America: Small Animal Practice, 33(3), 573–596. https://doi.org/10.1016/S0195-5616(03)00020-2.CrossRef

125.

Chocteau, F., Abadie, J., Loussouarn, D., & Nguyen, F. (2019). Proposal for a histological staging system of mammary carcinomas in dogs and cats. Part 1: Canine mammary carcinomas. Frontiers in Veterinary Science, 6, 388. https://doi.org/10.3389/fvets.2019.00388.

126.

Chocteau, F., Boulay, M.-M., Besnard, F., Valeau, G., Loussouarn, D., & Nguyen, F. (2019). Proposal for a histological staging system of mammary carcinomas in dogs and cats. Part 2: Feline mammary carcinomas. Frontiers in veterinary science, 6, 387. https://doi.org/10.3389/fvets.2019.00387.

127.

Moe, L. (2001). Population-based incidence of mammary tumours in some dog breeds. Journal of Reproduction and Fertility. Supplement, 57, 439–443.PubMed

128.

Weigelt, B., Peterse, J. L., & van ‘t Veer, L. J. (2005). Breast cancer metastasis: Markers and models. Nature reviews. Cancer, 5(8), 591–602. https://doi.org/10.1038/nrc1670.CrossRefPubMed

129.

Gundim, L. F., de Araújo, C. P., Blanca, W. T., Guimarães, E. C., & Medeiros, A. A. (2016). Clinical staging in bitches with mammary tumors: Influence of type and histological grade. Canadian Journal of Veterinary Research = Revue Canadienne De Recherche Veterinaire, 80(4), 318–322.PubMedPubMedCentral

130.

Bukowski, J. A., Wartenberg, D., & Goldschmidt, M. (1998). Environmental causes for sinonasal cancers in pet dogs, and their usefulness as sentinels of indoor cancer risk. Journal of toxicology and environmental health. Part A, 54(7), 579–591. https://doi.org/10.1080/009841098158719.CrossRef

131.

Patronek, G. J., Waters, D. J., & Glickman, L. T. (1997). Comparative longevity of pet dogs and humans: Implications for gerontology research. The journals of gerontology. Series A, Biological Sciences and Medical Sciences, 52(3), B171–B178. https://doi.org/10.1093/gerona/52a.3.b171.CrossRef

132.

Misdorp, W., & Hart, A. A. (1979). Canine mammary cancer. II. Therapy and causes of death. The Journal of Small Animal Practice, 20(7), 395–404. https://doi.org/10.1111/j.1748-5827.1979.tb06744.x.CrossRefPubMed

133.

Hayes, H. M., & Fraumeni, J. F. (1977). Epidemiological features of canine renal neoplasms. Cancer Research, 37(8 Pt 1), 2553–2556.PubMed

134.

Withrow, S. J., Vail, D. M., & Page, R. L. (Eds.). (2013). Withrow & MacEwen’s small animal clinical oncology (5th ed.). St. Louis, Missouri: Elsevier.

135.

Caliari, D., Zappulli, V., Rasotto, R., Cardazzo, B., Frassineti, F., Goldschmidt, M. H., & Castagnaro, M. (2014). Triple-negative vimentin-positive heterogeneous feline mammary carcinomas as a potential comparative model for breast cancer. BMC Veterinary Research, 10(1), 185. https://doi.org/10.1186/s12917-014-0185-8.CrossRefPubMedPubMedCentral

136.

De Maria, R., Olivero, M., Iussich, S., Nakaichi, M., Murata, T., Biolatti, B., & Di Renzo, M. F. (2005). Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer. Cancer Research, 65(3), 907–912.PubMed

137.

Supsavhad, W., Dirksen, W. P., Martin, C. K., & Rosol, T. J. (2016). Animal models of head and neck squamous cell carcinoma. The Veterinary Journal, 210, 7–16. https://doi.org/10.1016/j.tvjl.2015.11.006.CrossRefPubMed

138.

Cannon, C. M. (2015). Cats, Cancer and comparative oncology. Veterinary sciences, 2(3), 111–126. https://doi.org/10.3390/vetsci2030111.CrossRefPubMedPubMedCentral

139.

Weijer, K., Head, K. W., Misdorp, W., & Hampe, J. F. (1972). Feline malignant mammary tumors. I. Morphology and Biology: Some Comparisons With Human and Canine Mammary Carcinomas. JNCI: Journal of the National Cancer Institute, 49(6), 1697–1704. https://doi.org/10.1093/jnci/49.6.1697.CrossRefPubMed

140.

MacEwen, E. G. (1990). Spontaneous tumors in dogs and cats: Models for the study of cancer biology and treatment. Cancer and Metatasis Review, 9(2), 125–136. https://doi.org/10.1007/BF00046339.CrossRef

141.

Murakami, Y., Tateyama, S., Rungsipipat, A., Uchida, K., & Yamaguchi, R. (2000). Immunohistochemical analysis of Cyclin a, Cyclin D1 and P53 in mammary tumors, squamous cell carcinomas and basal cell tumors of dogs and cats. Journal of Veterinary Medical Science, 62(7), 743–750. https://doi.org/10.1292/jvms.62.743.CrossRef

142.

Murakami, Y., Tateyama, S., Rungsipipat, A., Uchida, K., & Yamaguchi, R. (2000). Amplification of the Cyclin a gene in canine and feline mammary tumors. Journal of Veterinary Medical Science, 62(7), 783–787. https://doi.org/10.1292/jvms.62.783.CrossRef

143.

Snyder, L. A., Bertone, E. R., Jakowski, R. M., Dooner, M. S., Jennings-Ritchie, J., & Moore, A. S. (2004). p53 expression and environmental tobacco smoke exposure in feline Oral squamous cell carcinoma. Veterinary Pathology, 41(3), 209–214. https://doi.org/10.1354/vp.41-3-209.CrossRefPubMed

144.

Ballegeer, E. A., Madrill, N. J., Berger, K. L., Agnew, D. W., & McNiel, E. A. (2013). Evaluation of hypoxia in a feline model of head and neck cancer using 64Cu-ATSM positron emission tomography/computed tomography. BMC Cancer, 13(1), 218. https://doi.org/10.1186/1471-2407-13-218.CrossRefPubMedPubMedCentral

145.

Rothenberg, S. M., & Ellisen, L. W. (2012). The molecular pathogenesis of head and neck squamous cell carcinoma. Journal of Clinical Investigation, 122(6), 1951–1957. https://doi.org/10.1172/JCI59889.CrossRef

146.

Wing Yuen, P., Man, M., Yin Lam, K., & Lam Kwong, Y. (2002). Clinicopathological significance of p16 gene expression in the surgical treatment of head and neck squamous cell carcinomas. Journal of Clinical Pathology, 55(1), 58–60. https://doi.org/10.1136/jcp.55.1.58.CrossRefPubMedPubMedCentral

147.

Munday, J. S., Knight, C. G., & French, A. F. (2011). Evaluation of feline oral squamous cell carcinomas for p16CDKN2A protein immunoreactivity and the presence of papillomaviral DNA. Research in Veterinary Science, 90(2), 280–283. https://doi.org/10.1016/j.rvsc.2010.06.014.CrossRefPubMed

148.

Rathore, K., Alexander, M., & Cekanova, M. (2014). Piroxicam inhibits Masitinib-induced cyclooxygenase 2 expression in oral squamous cell carcinoma cells in vitro. Translational Research: The Journal of Laboratory and Clinical Medicine, 164(2), 158–168. https://doi.org/10.1016/j.trsl.2014.02.002.CrossRef

149.

Ferrarotto, R., & Gold, K. A. (2014). Afatinib in the treatment of head and neck squamous cell carcinoma. Expert Opinion on Investigational Drugs, 23(1), 135–143. https://doi.org/10.1517/13543784.2014.858696.CrossRefPubMed

150.

Gardner, D. (2008). Spontaneous squamous cell carcinomas of the oral region in domestic animals: A review and consideration of their relevance to human research. Oral Diseases, 2(2), 148–154. https://doi.org/10.1111/j.1601-0825.1996.tb00216.x.CrossRef

151.

Jimi, E., Shin, M., Furuta, H., Tada, Y., & Kusukawa, J. (2013). The RANKL/RANK system as a therapeutic target for bone invasion by oral squamous cell carcinoma. International Journal of Oncology, 42(3), 803–809. https://doi.org/10.3892/ijo.2013.1794.CrossRefPubMed

152.

Wypij, J. M. (2013). A naturally occurring feline model of Head and neck squamous cell carcinoma. Pathology Research International, 2013, 1–7. https://doi.org/10.1155/2013/502197.CrossRef

153.

Soltero-Rivera, M. M., Krick, E. L., Reiter, A. M., Brown, D. C., & Lewis, J. R. (2014). Prevalence of regional and distant metastasis in cats with advanced oral squamous cell carcinoma: 49 cases (2005–2011). Journal of Feline Medicine and Surgery, 16(2), 164–169. https://doi.org/10.1177/1098612X13502975.CrossRefPubMed

154.

Genden, E. M., Ferlito, A., Bradley, P. J., Rinaldo, A., & Scully, C. (2003). Neck disease and distant metastases. Oral Oncology, 39(3), 207–212. https://doi.org/10.1016/S1368-8375(02)00049-0.CrossRefPubMed

155.

Groenen, M. A. M., Archibald, A. L., Uenishi, H., Tuggle, C. K., Takeuchi, Y., Rothschild, M. F., et al. (2012). Analyses of pig genomes provide insight into porcine demography and evolution. Nature, 491(7424), 393–398. https://doi.org/10.1038/nature11622.CrossRefPubMedPubMedCentral

156.

Arnold, C. R., Kloss, F., Singh, S., Vasiljevic, D., Stigler, R., Auberger, T., et al. (2017). A domestic porcine model for studying the effects of radiation on head and neck cancers. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 123(5), 536–543. https://doi.org/10.1016/j.oooo.2016.11.017.CrossRefPubMed

157.

Xu, J., Zheng, Z., Fang, D., Gao, R., Liu, Y., Fan, Z. P., et al. (2012). Early-stage pathogenic sequence of jaw osteoradionecrosis in vivo. Journal of Dental Research, 91(7), 702–708. https://doi.org/10.1177/0022034512448661.CrossRefPubMed

158.

Verdonck, H. W. D., Meijer, G. J., Laurin, T., Nieman, F. H., Stoll, C., Riediger, D., et al. (2008). Implant stability during osseointegration in irradiated and non-irradiated minipig alveolar bone: An experimental study. Clinical Oral Implants Research, 19(2), 201–206. https://doi.org/10.1111/j.1600-0501.2007.01457.x.CrossRefPubMed

159.

Overgaard, N. H., Frøsig, T. M., Welner, S., Rasmussen, M., Ilsøe, M., Sørensen, M. R., et al. (2015). Establishing the pig as a large animal model for vaccine development against human cancer. Frontiers in Genetics, 6. https://doi.org/10.3389/fgene.2015.00286.

160.

Youssef, G., Wallace, W. A. H., Dagleish, M. P., Cousens, C., & Griffiths, D. J. (2015). Ovine pulmonary adenocarcinoma: A large animal model for human lung Cancer. ILAR Journal, 56(1), 99–115. https://doi.org/10.1093/ilar/ilv014.CrossRefPubMed

161.

Perk, K., & Hod, I. (1982). Sheep lung carcinoma: An endemic analogue of a sporadic human neoplasm. Journal of the National Cancer Institute, 69(4), 747–749.PubMed

162.

Martin, W. B., Scott, F. M., Sharp, J. M., Angus, K. W., & Norval, M. (1976). Experimental production of sheep pulmonary adenomatosis (Jaagsiekte). Nature, 264(5582), 183–185. https://doi.org/10.1038/264183a0.CrossRefPubMed

163.

Sharp, J. M., Angus, K. W., Gray, E. W., & Scott, F. M. (1983). Rapid transmission of sheep pulmonary adenomatosis (jaagsiekte) in young lambs. Brief report. Archives of Virology, 78(1–2), 89–95. https://doi.org/10.1007/BF01310861.CrossRefPubMed

164.

Summers, C., Norval, M., De Las Heras, M., Gonzalez, L., Sharp, J. M., & Woods, G. M. (2005). An influx of macrophages is the predominant local immune response in ovine pulmonary adenocarcinoma. Veterinary Immunology and Immunopathology, 106(3–4), 285–294. https://doi.org/10.1016/j.vetimm.2005.03.006.CrossRefPubMed

165.

van der Weyden, L., Patton, E. E., Wood, G. A., Foote, A. K., Brenn, T., Arends, M. J., & Adams, D. J. (2016). Cross-species models of human melanoma: Cross-species models of human melanoma. The Journal of Pathology, 238(2), 152–165. https://doi.org/10.1002/path.4632.CrossRefPubMed

166.

Coricovac, D., Dehelean, C., Moaca, E.-A., Pinzaru, I., Bratu, T., Navolan, D., & Boruga, O. (2018). Cutaneous melanoma-a long road from experimental models to clinical outcome: A review. International Journal of Molecular Sciences, 19(6). https://doi.org/10.3390/ijms19061566.

167.

Valentine, B. A. (1995). Equine melanocytic tumors: A retrospective study of 53 horses (1988 to 1991). Journal of Veterinary Internal Medicine, 9(5), 291–297. https://doi.org/10.1111/j.1939-1676.1995.tb01087.x.CrossRefPubMed

168.

Smith, S. H., Goldschmidt, M. H., & McManus, P. M. (2002). A comparative review of melanocytic neoplasms. Veterinary Pathology, 39(6), 651–678. https://doi.org/10.1354/vp.39-6-651.CrossRefPubMed

169.

Schöniger, S., & Summers, B. A. (2009). Equine skin tumours in 20 horses resembling three variants of human melanocytic naevi. Veterinary Dermatology, 20(3), 165–173. https://doi.org/10.1111/j.1365-3164.2009.00741.x.CrossRefPubMed

170.

Rosengren Pielberg, G., Golovko, A., Sundström, E., Curik, I., Lennartsson, J., Seltenhammer, M. H., et al. (2008). A cis-acting regulatory mutation causes premature hair graying and susceptibility to melanoma in the horse. Nature Genetics, 40(8), 1004–1009. https://doi.org/10.1038/ng.185.CrossRefPubMed

171.

Mohan, H. M., Aherne, C. M., Rogers, A. C., Baird, A. W., Winter, D. C., & Murphy, E. P. (2012). Molecular pathways: The role of NR4A orphan nuclear receptors in Cancer. Clinical Cancer Research, 18(12), 3223–3228. https://doi.org/10.1158/1078-0432.CCR-11-2953.CrossRefPubMed

172.

Maccioni, L., Rachakonda, P. S., Scherer, D., Bermejo, J. L., Planelles, D., Requena, C., et al. (2013). Variants at chromosome 20 (ASIP locus) and melanoma risk. International Journal of Cancer, 132(1), 42–54. https://doi.org/10.1002/ijc.27648.CrossRefPubMed

173.

MacGillivray, K. C., Sweeney, R. W., & Del Piero, F. (2002). Metastatic melanoma in horses. Journal of Veterinary Internal Medicine, 16(4), 452–456. https://doi.org/10.1892/0891-6640(2002)016<0452:mmih>2.3.co;2.CrossRefPubMed

174.

Suárez-Bonnet, A., Willis, C., Pittaway, R., Smith, K., Mair, T., & Priestnall, S. L. (2018). Molecular carcinogenesis in equine penile cancer: A potential animal model for human penile cancer. Urologic Oncology: Seminars and Original Investigations, 36(12), 532.e9–532.e18. https://doi.org/10.1016/j.urolonc.2018.09.004.CrossRef

175.

Sykora, S., Jindra, C., Hofer, M., Steinborn, R., & Brandt, S. (2017) Equine papillomavirus type 2: An equine equivalent to human papillomavirus 16? Veterinary Journal (London, England 1997), 225, 3–8. https://doi.org/10.1016/j.tvjl.2017.04.014.

176.

Shabbir, M., Kayes, O., & Minhas, S. (2014). Challenges and controversies in the management of penile cancer. Nature reviews. Urology, 11(12), 702–711. https://doi.org/10.1038/nrurol.2014.307.CrossRefPubMed

177.

Johnson, P. A., & Giles, J. R. (2013). The hen as a model of ovarian cancer. Nature Reviews Cancer, 13(6), 432–436. https://doi.org/10.1038/nrc3535.CrossRefPubMed

178.

Urick, M. E., Giles, J. R., & Johnson, P. A. (2009). Dietary aspirin decreases the stage of ovarian cancer in the hen. Gynecologic Oncology, 112(1), 166–170. https://doi.org/10.1016/j.ygyno.2008.09.032.CrossRefPubMed

179.

Fredrickson, T. N. (1987). Ovarian tumors of the hen. Environmental Health Perspectives, 73, 35–51. https://doi.org/10.1289/ehp.877335.CrossRefPubMedPubMedCentral

180.

Auersperg, N., Wong, A. S., Choi, K. C., Kang, S. K., & Leung, P. C. (2001). Ovarian surface epithelium: Biology, endocrinology, and pathology. Endocrine Reviews, 22(2), 255–288. https://doi.org/10.1210/edrv.22.2.0422.CrossRefPubMed

181.

McCluggage, W. G. (2011). Morphological subtypes of ovarian carcinoma: A review with emphasis on new developments and pathogenesis. Pathology, 43(5), 420–432. https://doi.org/10.1097/PAT.0b013e328348a6e7.CrossRefPubMed

182.

Ansenberger, K., Zhuge, Y., Lagman, J. A. J., Richards, C., Barua, A., Bahr, J. M., & Hales, D. B. (2009). E-cadherin expression in ovarian cancer in the laying hen, Gallus domesticus, compared to human ovarian cancer. Gynecologic Oncology, 113(3), 362–369. https://doi.org/10.1016/j.ygyno.2009.02.011.CrossRefPubMedPubMedCentral

183.

Urick, M. E., Giles, J. R., & Johnson, P. A. (2008). VEGF expression and the effect of NSAIDs on ascites cell proliferation in the hen model of ovarian cancer. Gynecologic Oncology, 110(3), 418–424. https://doi.org/10.1016/j.ygyno.2008.05.018.CrossRefPubMed

184.

Rodríguez-Burford, C., Barnes, M. N., Berry, W., Partridge, E. E., & Grizzle, W. E. (2001). Immunohistochemical expression of molecular markers in an avian model: A potential model for preclinical evaluation of agents for ovarian cancer chemoprevention. Gynecologic Oncology, 81(3), 373–379. https://doi.org/10.1006/gyno.2001.6191.CrossRefPubMed

185.

Hakim, A. A., Barry, C. P., Barnes, H. J., Anderson, K. E., Petitte, J., Whitaker, R., et al. (2009). Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neu. Cancer Prevention Research (Philadelphia, Pa.), 2(2), 114–121. https://doi.org/10.1158/1940-6207.CAPR-08-0065.CrossRef

186.

Wernli, K. J., Newcomb, P. A., Hampton, J. M., Trentham-Dietz, A., & Egan, K. M. (2008). Inverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parity. British Journal of Cancer, 98(11), 1781–1783. https://doi.org/10.1038/sj.bjc.6604392.CrossRefPubMedPubMedCentral

187.

Barnes, M. N., Berry, W. D., Straughn, J. M. J., Kirby, T. O., Leath, C. A., Huh, W. K., et al. (2002). A pilot study of ovarian cancer chemoprevention using medroxyprogesterone acetate in an avian model of spontaneous ovarian carcinogenesis. Gynecologic Oncology, 87(1), 57–63. https://doi.org/10.1006/gyno.2002.6806.CrossRefPubMed

188.

Treviño, L. S., Buckles, E. L., & Johnson, P. A. (2012). Oral contraceptives decrease the prevalence of ovarian cancer in the hen. Cancer Prevention Research (Philadelphia, Pa.), 5(2), 343–349. https://doi.org/10.1158/1940-6207.CAPR-11-0344.CrossRef

189.

Sueblinvong, T., & Carney, M. E. (2009). Current understanding of risk factors for ovarian cancer. Current Treatment Options in Oncology, 10(1–2), 67–81. https://doi.org/10.1007/s11864-009-0108-2.CrossRefPubMed

190.

Pal, P., Hales, K., Petrik, J., & Hales, D. B. (2019). Pro-apoptotic and anti-angiogenic actions of 2-methoxyestradiol and docosahexaenoic acid, the biologically derived active compounds from flaxseed diet, in preventing ovarian cancer. Journal of Ovarian Research, 12(1), 49. https://doi.org/10.1186/s13048-019-0523-3.CrossRefPubMedPubMedCentral

191.

Dikshit, A., Hales, K., & Hales, D. B. (2017). Whole flaxseed diet alters estrogen metabolism to promote 2-methoxtestradiol-induced apoptosis in hen ovarian cancer. The Journal of Nutritional Biochemistry, 42, 117–125. https://doi.org/10.1016/j.jnutbio.2017.01.002.CrossRefPubMedPubMedCentral

192.

Sahin, K., Yenice, E., Bilir, B., Orhan, C., Tuzcu, M., Sahin, N., et al. (2019). Genistein prevents development of spontaneous ovarian Cancer and inhibits tumor growth in hen model. Cancer Prevention Research, 12(3), 135–146. https://doi.org/10.1158/1940-6207.CAPR-17-0289.CrossRefPubMed

193.

Sahin, K., Yenice, E., Tuzcu, M., Orhan, C., Mizrak, C., Ozercan, I. H., et al. (2018). Lycopene protects against spontaneous ovarian cancer formation in laying hens. Journal of Cancer Prevention, (1), 23, 25–36. https://doi.org/10.15430/JCP.2018.23.1.25.

194.

Burrell, G. A., & Seibert, F. M. (1914). Experiments with small animals and carbon monoxide. Journal of Industrial & Engineering Chemistry, 6(3), 241–244. https://doi.org/10.1021/ie50063a027.CrossRef

195.

Glantz, S. A. (1995). Passive smoking and heart disease. Mechanisms and risk. JAMA: The Journal of the American Medical Association, 273(13), 1047–1053. https://doi.org/10.1001/jama.273.13.1047.CrossRefPubMed

196.

Jaakkola, M., & Jakkola, J. (2002). Effects of environmental tobacco smoke on the respiratory health of adults. Scandinavian Journal of Work, Environment & Health, 28, 52–70.

197.

Asomaning, K., Miller, D. P., Liu, G., Wain, J. C., Lynch, T. J., Su, L., & Christiani, D. C. (2008). Second hand smoke, age of exposure and lung cancer risk. Lung Cancer, 61(1), 13–20. https://doi.org/10.1016/j.lungcan.2007.11.013.CrossRefPubMedPubMedCentral

198.

Reif, J. S., Dunn, K., Ogilvie, G. K., & Harris, C. K. (1992). Passive smoking and canine lung Cancer risk. American Journal of Epidemiology, 135(3), 234–239. https://doi.org/10.1093/oxfordjournals.aje.a116276.CrossRefPubMed

199.

Zierenberg-Ripoll, A., Pollard, R. E., Stewart, S. L., Allstadt, S. D., Barrett, L. E., Gillem, J. M., & Skorupski, K. A. (2018). Association between environmental factors including second-hand smoke and primary lung cancer in dogs: Tobacco smoke and lung cancer. Journal of Small Animal Practice, 59(6), 343–349. https://doi.org/10.1111/jsap.1277.8.CrossRef

200.

Khuder, S. A. (2001). Effect of cigarette smoking on major histological types of lung cancer: A meta-analysis. Lung Cancer, 31(2–3), 139–148. https://doi.org/10.1016/S0169-5002(00)00181-1.CrossRefPubMed

201.

Ogilvie, G., Haschek, W., Withrow, S. J., Richardson, R., Harvey, H., Henderson, R., & Fowler, J. (1989). Classification of primary lung tumors in dogs: 210 cases (1975-1985). Journal of the Veterinary Medical Association, 195, 106–108.

202.

Bertone, E. R., Snyder, L. A., & Moore, A. S. (2003). Environmental and lifestyle risk factors for oral squamous cell carcinoma in domestic cats. Journal of Veterinary Internal Medicine, 17(4), 557–562. https://doi.org/10.1111/j.1939-1676.2003.tb02478.x.CrossRefPubMed

203.

Hayes, H. M., Hoover, R., & Tarone, R. E. (1981). Bladder cancer in pet dogs: A sentinel for human cancer? American Journal of Epidemiology, 114(2), 229–233. https://doi.org/10.1093/oxfordjournals.aje.a113186.CrossRefPubMed

204.

Garbe, P. (1988). The companion animal as a sentinal for environmentally related human diseases. Acta Veterinaria Scandinavica. Supplementum, 84, 290–292.PubMed

205.

Glickman, L. T., Schofer, F. S., McKee, L. J., Reif, J. S., & Goldschmidt, M. H. (1989). Epidemiologic study of insecticide exposures, obesity, and risk of bladder cancer in household dogs. Journal of Toxicology and Environmental Health, 28(4), 407–414. https://doi.org/10.1080/15287398909531360.CrossRefPubMed

206.

Koutros, S., Silverman, D. T., Alavanja, M. C., Andreotti, G., Lerro, C. C., Heltshe, S., et al. (2016). Occupational exposure to pesticides and bladder cancer risk. International Journal of Epidemiology, 45(3), 792–805. https://doi.org/10.1093/ije/dyv195.CrossRefPubMed

207.

Liang, Z., Wang, X., Xie, B., Zhu, Y., Wu, J., Li, S., et al. (2016). Pesticide exposure and risk of bladder cancer: A meta-analysis. Oncotarget, 7(41), 66959–66969. https://doi.org/10.18632/oncotarget.11397.CrossRefPubMedPubMedCentral

208.

Kingsley, M. C. S. (1998). Population index estimates for the St. Lawrence belugas, 1973–1995. Marine Mammal Science, 14(3), 508–529. https://doi.org/10.1111/j.1748-7692.1998.tb00739.x.CrossRef

209.

Martineau, D., Lemberger, K., Dallaire, A., Labelle, P., Lipscomb, T. P., Michel, P., & Mikaelian, I. (2002). Cancer in wildlife, a case study: Beluga from the St. Lawrence estuary, Québec, Canada. Environmental Health Perspectives, 110(3), 285–292. https://doi.org/10.1289/ehp.02110285.CrossRefPubMedPubMedCentral

210.

Béland, P., DeGuise, S., Girard, C., Lagacé, A., Martineau, D., Michaud, R., et al. (1993). Toxic compounds and health and reproductive effects in St. Lawrence Beluga whales. Journal of Great Lakes Research, 19(4), 766–775. https://doi.org/10.1016/S0380-1330(93)71264-2.CrossRef

211.

Lair, S., Measures, L. N., & Martineau, D. (2016). Pathologic findings and trends in mortality in the Beluga (Delphinapterus leucas ) population of the St Lawrence estuary, Quebec, Canada, from 1983 to 2012. Veterinary Pathology, 53(1), 22–36. https://doi.org/10.1177/0300985815604726.CrossRefPubMed

212.

Lesage, V., & Kingsley, M. (1998). Updated status of the St. Lawrence River population of the Beluga Delphinapterus leucas. Canadian Field-Naturalist, 112, 98–113.

213.

Montiel-León, J. M., Munoz, G., Vo Duy, S., Do, D. T., Vaudreuil, M.-A., Goeury, K., et al. (2019). Widespread occurrence and spatial distribution of glyphosate, atrazine, and neonicotinoids pesticides in the St. Lawrence and tributary rivers. Environmental Pollution, 250, 29–39. https://doi.org/10.1016/j.envpol.2019.03.125.CrossRefPubMed

214.

Montiel-León, J. M., Vo Duy, S., Munoz, G., Bouchard, M. F., Amyot, M., & Sauvé, S. (2019). Quality survey and spatiotemporal variations of atrazine and desethylatrazine in drinking water in Quebec, Canada. Science of the Total Environment, 671, 578–585. https://doi.org/10.1016/j.scitotenv.2019.03.228.CrossRef

215.

Falkmer, S., Marklund, S., Mattsson, P. E., & Rappe, C. (1977). Hepatomas and other neoplasms in the Atlantic hagfish (Myxine Glutinosa): A Histopathologic and chemical study. Annals of the New York Academy of Sciences, 298(1 aquatic Pollu), 342–355. https://doi.org/10.1111/j.1749-6632.1977.tb19277.x.CrossRef

216.

Falkmer, S. (1998). The tumour pathology of Myxine Glutinosa. In The biology of hagfishes (pp. 101–105). Dordrecht: Springer Netherlands. https://doi.org/10.1007/978-94-011-5834-3_7.CrossRef

217.

Essack, S. Y. (2018). Environment: The neglected component of the one health triad. The Lancet Planetary Health, 2(6), e238–e239. https://doi.org/10.1016/S2542-5196(18)30124-4.CrossRefPubMedPubMedCentral

218.

Harada, T., Takeda, M., Kojima, S., & Tomiyama, N. (2016). Toxicity and carcinogenicity of dichlorodiphenyltrichloroethane (DDT). Toxicological Research, 32(1), 21–33. https://doi.org/10.5487/TR.2016.32.1.021.CrossRefPubMedPubMedCentral

219.

Abu-Helil, B., & van der Weyden, L. (2019). Metastasis in the wild: Investigating metastasis in non-laboratory animals. Clinical & Experimental Metastasis, 36(1), 15–28. https://doi.org/10.1007/s10585-019-09956-3.CrossRef

220.

Yang, Z., Zhang, Y., & Chen, L. (2013). Investigation of anti-cancer mechanisms by comparative analysis of naked mole rat and rat. BMC Systems Biology, 7(Suppl 2), S5. https://doi.org/10.1186/1752-0509-7-S2-S5.CrossRefPubMedPubMedCentral

221.

Schülke, S., Dreidax, D., Malik, A., Burmester, T., Nevo, E., Band, M., et al. (2012). Living with stress: Regulation of antioxidant defense genes in the subterranean, hypoxia-tolerant mole rat, Spalax. Gene, 500(2), 199–206. https://doi.org/10.1016/j.gene.2012.03.019.CrossRefPubMed

222.

Kshitiz, Afzal, J., Maziarz, J. D., Hamidzadeh, A., Liang, C., Erkenbrack, E. M., … Wagner, G. P. (2019). Evolution of placental invasion and cancer metastasis are causally linked. Nature Ecology & Evolution, 3(12), 1743–1753. https://doi.org/10.1038/s41559-019-1046-4.

223.

Defourny, S., Romanucci, M., Grieco, V., Quaglione, G., Santolini, C., & Della Salda, L. (2019). Tumor–microenvironment interaction: Analysis of mast cell populations in normal tissue and proliferative disorders of the canine prostate. Veterinary Sciences, 6(1), 16. https://doi.org/10.3390/vetsci6010016.CrossRefPubMedCentral

224.

Carvalho, M. I., Silva-Carvalho, R., Pires, I., Prada, J., Bianchini, R., Jensen-Jarolim, E., & Queiroga, F. L. (2016). A comparative approach of tumor-associated inflammation in mammary Cancer between humans and dogs. BioMed Research International, 2016, 1–12. https://doi.org/10.1155/2016/4917387.CrossRef

225.

Gorbunova, V., Seluanov, A., Zhang, Z., Gladyshev, V. N., & Vijg, J. (2014). Comparative genetics of longevity and cancer: Insights from long-lived rodents. Nature reviews. Genetics, 15(8), 531–540. https://doi.org/10.1038/nrg3728.CrossRefPubMed

226.

Ma, S., & Gladyshev, V. N. (2017). Molecular signatures of longevity: Insights from cross-species comparative studies. Seminars in Cell & Developmental Biology, 70, 190–203. https://doi.org/10.1016/j.semcdb.2017.08.007.CrossRef

227.

Seluanov, A., Gladyshev, V. N., Vijg, J., & Gorbunova, V. (2018). Mechanisms of cancer resistance in long-lived mammals. Nature reviews. Cancer, 18(7), 433–441. https://doi.org/10.1038/s41568-018-0004-9.CrossRefPubMed

228.

Tian, X., Azpurua, J., Hine, C., Vaidya, A., Myakishev-Rempel, M., Ablaeva, J., et al. (2013). High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat. Nature, 499(7458), 346–349. https://doi.org/10.1038/nature12234.CrossRefPubMedPubMedCentral

229.

Seluanov, A., Hine, C., Azpurua, J., Feigenson, M., Bozzella, M., Mao, Z., et al. (2009). Hypersensitivity to contact inhibition provides a clue to cancer resistance of naked mole-rat. Proceedings of the National Academy of Sciences, 106(46), 19352. https://doi.org/10.1073/pnas.0905252106.CrossRef

230.

Kurz, S., Thieme, R., Amberg, R., Groth, M., Jahnke, H.-G., Pieroh, P., et al. (2017). The anti-tumorigenic activity of A2M—A lesson from the naked mole-rat. PLoS One, 12(12). https://doi.org/10.1371/journal.pone.0189514.

231.

Zhao, Y., Tyshkovskiy, A., Muñoz-Espín, D., Tian, X., Serrano, M., de Magalhaes, J. P., et al. (2018). Naked mole rats can undergo developmental, oncogene-induced and DNA damage-induced cellular senescence. Proceedings of the National Academy of Sciences, 115(8), 1801–1806. https://doi.org/10.1073/pnas.1721160115.CrossRef

232.

Tan, L., Ke, Z., Tombline, G., Macoretta, N., Hayes, K., Tian, X., et al. (2017). Naked mole rat cells have a stable Epigenome that resists iPSC reprogramming. Stem Cell Reports, 9(5), 1721–1734. https://doi.org/10.1016/j.stemcr.2017.10.001.CrossRefPubMedPubMedCentral

233.

Miyawaki, S., Kawamura, Y., Oiwa, Y., Shimizu, A., Hachiya, T., Bono, H., et al. (2016). Tumour resistance in induced pluripotent stem cells derived from naked mole-rats. Nature Communications, 7(1), 11471. https://doi.org/10.1038/ncomms11471.CrossRefPubMedPubMedCentral

234.

MacRae, S. L., Zhang, Q., Lemetre, C., Seim, I., Calder, R. B., Hoeijmakers, J., et al. (2015). Comparative analysis of genome maintenance genes in naked mole rat, mouse, and human. Aging Cell, 14(2), 288–291. https://doi.org/10.1111/acel.12314.CrossRefPubMedPubMedCentral

235.

Kim, E. B., Fang, X., Fushan, A. A., Huang, Z., Lobanov, A. V., Han, L., et al. (2011). Genome sequencing reveals insights into physiology and longevity of the naked mole rat. Nature, 479(7372), 223–227. https://doi.org/10.1038/nature10533.CrossRefPubMedPubMedCentral

236.

Evdokimov, A., Kutuzov, M., Petruseva, I., Lukjanchikova, N., Kashina, E., Kolova, E., et al. (2018). Naked mole rat cells display more efficient excision repair than mouse cells. Aging (Albany NY), 10(6), 1454–1473. https://doi.org/10.18632/aging.101482.CrossRef

237.

Gorbunova, V., Hine, C., Tian, X., Ablaeva, J., Gudkov, A. V., Nevo, E., & Seluanov, A. (2012). Cancer resistance in the blind mole rat is mediated by concerted necrotic cell death mechanism. Proceedings of the National Academy of Sciences of the United States of America, 109(47), 19392–19396. https://doi.org/10.1073/pnas.1217211109.CrossRefPubMedPubMedCentral

238.

Manov, I., Hirsh, M., Iancu, T. C., Malik, A., Sotnichenko, N., Band, M., et al. (2013). Pronounced cancer resistance in a subterranean rodent, the blind mole-rat, Spalax: In vivo and in vitroevidence. BMC Biology, 11(1), 91. https://doi.org/10.1186/1741-7007-11-91.CrossRefPubMedPubMedCentral

239.

Nasser, N. J., Avivi, A., Shafat, I., Edovitsky, E., Zcharia, E., Ilan, N., et al. (2009). Alternatively spliced Spalax heparanase inhibits extracellular matrix degradation, tumor growth, and metastasis. Proceedings of the National Academy of Sciences, 106(7), 2253–2258. https://doi.org/10.1073/pnas.0812846106.CrossRef

240.

Abegglen, L. M., Caulin, A. F., Chan, A., Lee, K., Robinson, R., Campbell, M. S., et al. (2015). Potential mechanisms for Cancer resistance in elephants and comparative cellular response to DNA damage in humans. Jama, 314(17), 1850–1860. https://doi.org/10.1001/jama.2015.13134.CrossRefPubMedPubMedCentral

241.

Sulak, M., Fong, L., Mika, K., Chigurupati, S., Yon, L., Mongan, N. P., … Lynch, V. J. (2016). TP53 copy number expansion is associated with the evolution of increased body size and an enhanced DNA damage response in elephants. eLife, 5, e11994. https://doi.org/10.7554/eLife.11994.

242.

Vazquez, J. M., Sulak, M., Chigurupati, S., & Lynch, V. J. (2018). A zombie LIF gene in elephants is Upregulated by TP53 to induce apoptosis in response to DNA damage. Cell Reports, 24(7), 1765–1776. https://doi.org/10.1016/j.celrep.2018.07.042.CrossRefPubMed

243.

Li, X., Caval, V., Wain-Hobson, S., & Vartanian, J.-P. (2019). Elephant APOBEC3A cytidine deaminase induces massive double-stranded DNA breaks and apoptosis. Scientific Reports, 9(1), 728. https://doi.org/10.1038/s41598-018-37305-z.CrossRefPubMedPubMedCentral

244.

Zhao, M., Kim, P., Mitra, R., Zhao, J., & Zhao, Z. (2016). TSGene 2.0: An updated literature-based knowledgebase for tumor suppressor genes. Nucleic Acids Research, 44(D1), D1023–D1031. https://doi.org/10.1093/nar/gkv1268.CrossRefPubMed

245.

Tollis, M., Robbins, J., Webb, A. E., Kuderna, L. F. K., Caulin, A. F., Garcia, J. D., et al. (2019). Return to the sea, get huge, beat Cancer: An analysis of cetacean genomes including an assembly for the humpback whale (Megaptera novaeangliae). Molecular Biology and Evolution, 36(8), 1746–1763. https://doi.org/10.1093/molbev/msz099.CrossRefPubMedPubMedCentral

246.

Brook, C. E., & Dobson, A. P. (2015). Bats as ‘special’ reservoirs for emerging zoonotic pathogens. Trends in Microbiology, 23(3), 172–180. https://doi.org/10.1016/j.tim.2014.12.004.CrossRefPubMedPubMedCentral

247.

Seim, I., Fang, X., Xiong, Z., Lobanov, A. V., Huang, Z., Ma, S., et al. (2013). Genome analysis reveals insights into physiology and longevity of the Brandt’s bat Myotis brandtii. Nature Communications, 4, 2212. https://doi.org/10.1038/ncomms3212.CrossRefPubMedPubMedCentral

248.

David, A., Hwa, V., Metherell, L. A., Netchine, I., Camacho-Hübner, C., Clark, A. J. L., et al. (2011). Evidence for a continuum of genetic, phenotypic, and biochemical abnormalities in children with growth hormone insensitivity. Endocrine Reviews, 32(4), 472–497. https://doi.org/10.1210/er.2010-0023.CrossRefPubMed

249.

Werner, H., Lapkina-Gendler, L., Achlaug, L., Nagaraj, K., Somri, L., Yaron-Saminsky, D., et al. (2019). Genome-wide profiling of laron syndrome patients identifies novel cancer protection pathways. Cells, 8(6). https://doi.org/10.3390/cells8060596.

250.

Huang, Z., Jebb, D., & Teeling, E. C. (2016). Blood miRNomes and transcriptomes reveal novel longevity mechanisms in the long-lived bat, Myotis myotis. BMC Genomics, 17(1), 906. https://doi.org/10.1186/s12864-016-3227-8.CrossRefPubMedPubMedCentral

251.

Koh, J., Itahana, Y., Mendenhall, I. H., Low, D., Soh, E. X. Y., Guo, A. K., et al. (2019). ABCB1 protects bat cells from DNA damage induced by genotoxic compounds. Nature Communications, 10(1), 2820. https://doi.org/10.1038/s41467-019-10495-4.CrossRefPubMedPubMedCentral

252.

Seluanov, A., Hine, C., Bozzella, M., Hall, A., Sasahara, T. H. C., Ribeiro, A. A. C. M., et al. (2008). Distinct tumor suppressor mechanisms evolve in rodent species that differ in size and lifespan. Aging Cell, 7(6), 813–823. https://doi.org/10.1111/j.1474-9726.2008.00431.x.CrossRefPubMedPubMedCentral

253.

Knight, C. H., & Sorensen, A. (2001). Windows in early mammary development: Critical or not? Reproduction (Cambridge, England), 122(3), 337–345. https://doi.org/10.1530/rep.0.1220337.CrossRef

254.

Munson, L., & Moresco, A. (2007). Comparative pathology of mammary gland cancers in domestic and wild animals. Breast Disease, 28, 7–21. https://doi.org/10.3233/bd-2007-28102.CrossRefPubMed

255.

Ledet, M. M., Oswald, M., Anderson, R., & Van de Walle, G. R. (2018). Differential signaling pathway activation in 7,12-dimethylbenz[a] anthracene (DMBA)-treated mammary stem/progenitor cells from species with varying mammary cancer incidence. Oncotarget, 9(67), 32761–32774. https://doi.org/10.18632/oncotarget.25988.CrossRefPubMedPubMedCentral

256.

Caulin, A. F., Graham, T. A., Wang, L.-S., & Maley, C. C. (2015). Solutions to Peto’s paradox revealed by mathematical modelling and cross-species cancer gene analysis. Philosophical Transactions of the Royal Society B: Biological Sciences, 370(1673), 20140222.CrossRef

257.

Nagy, J. D. (2005). The ecology and evolutionary biology of cancer: A review of mathematical models of necrosis and tumor cell diversity. Mathematical biosciences and engineering: MBE, 2(2), 381–418. https://doi.org/10.3934/mbe.2005.2.381.CrossRefPubMed

258.

Nagy, J. D., Victor, E. M., & Cropper, J. H. (2007). Why don’t all whales have cancer? A novel hypothesis resolving Peto’s paradox. Integrative and Comparative Biology, 47(2), 317–328. https://doi.org/10.1093/icb/icm062.CrossRefPubMed

ACC 2024 Congress

Springer Medicine

Beyond tradition and convention: benefits of non-traditional model organisms in cancer research

Abstract

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

ACC 2024 Congress

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2021

Secreted frizzled-related protein 2: a key player in noncanonical Wnt signaling and tumor angiogenesis

Safety of radiosurgery concurrent with systemic therapy (chemotherapy, targeted therapy, and/or immunotherapy) in brain metastases: a systematic review

Potential mechanisms of tumor progression associated with postoperative infectious complications

Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma—backbone or add-on in immune-oncology?

Epigenetic modulation of immunotherapy and implications in head and neck cancer

Cohesive cancer invasion of the biophysical barrier of smooth muscle

Keynote webinar | Spotlight on antibody–drug conjugates in cancer